SI9620090A - Ionski molekulski konjugati N-aciliranih derivatov poli (2-amino-2-deoksi-D-glukoze) in polipeptidov - Google Patents

Ionski molekulski konjugati N-aciliranih derivatov poli (2-amino-2-deoksi-D-glukoze) in polipeptidov Download PDF

Info

Publication number
SI9620090A
SI9620090A SI9620090A SI9620090A SI9620090A SI 9620090 A SI9620090 A SI 9620090A SI 9620090 A SI9620090 A SI 9620090A SI 9620090 A SI9620090 A SI 9620090A SI 9620090 A SI9620090 A SI 9620090A
Authority
SI
Slovenia
Prior art keywords
acyl group
group
percent
polypeptide
acylating agent
Prior art date
Application number
SI9620090A
Other languages
English (en)
Slovenian (sl)
Inventor
W. Shalaby Shalaby
A. Steven Jackson
Francis Ignatious
Jacques-Pierre Moreau
Original Assignee
Biomeasure Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Incorporated filed Critical Biomeasure Incorporated
Publication of SI9620090A publication Critical patent/SI9620090A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
SI9620090A 1995-06-06 1996-05-24 Ionski molekulski konjugati N-aciliranih derivatov poli (2-amino-2-deoksi-D-glukoze) in polipeptidov SI9620090A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/468,947 US5665702A (en) 1995-06-06 1995-06-06 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
PCT/US1996/007756 WO1996039160A1 (en) 1995-06-06 1996-05-24 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides

Publications (1)

Publication Number Publication Date
SI9620090A true SI9620090A (sl) 1998-08-31

Family

ID=23861854

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9620090A SI9620090A (sl) 1995-06-06 1996-05-24 Ionski molekulski konjugati N-aciliranih derivatov poli (2-amino-2-deoksi-D-glukoze) in polipeptidov

Country Status (21)

Country Link
US (2) US5665702A (hu)
EP (1) EP0830137B1 (hu)
JP (1) JPH11508289A (hu)
KR (1) KR19990022399A (hu)
CN (1) CN1192152A (hu)
AT (1) ATE245031T1 (hu)
AU (1) AU717188B2 (hu)
BR (1) BR9609031A (hu)
CA (1) CA2222995C (hu)
CZ (1) CZ391697A3 (hu)
DE (1) DE69629114T2 (hu)
DK (1) DK0830137T3 (hu)
ES (1) ES2201188T3 (hu)
HU (1) HUP9901627A3 (hu)
NZ (1) NZ308909A (hu)
PL (1) PL323735A1 (hu)
PT (1) PT830137E (hu)
RU (1) RU2172323C2 (hu)
SI (1) SI9620090A (hu)
SK (1) SK168397A3 (hu)
WO (1) WO1996039160A1 (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US6479457B2 (en) * 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
AR014069A1 (es) 1998-01-29 2001-01-31 Kinerton Ltd Procedimiento para preparar microparticula o microparticulas unidas encapsuladas
JP3842042B2 (ja) * 1998-01-29 2006-11-08 ポリ−メド・インコーポレーテッド 吸収可能なマイクロ粒子
PT1137666E (pt) 1998-12-07 2008-06-02 Sod Conseils Rech Applic Análogos de glp-1
JP4532618B2 (ja) * 1999-02-25 2010-08-25 株式会社グライコメディクス 新規糖鎖プライマー
WO2002022154A2 (en) 2000-09-13 2002-03-21 Praecis Pharmaceuticals Incorporated Pharmaceutical compositions for sustained drug delivery
US7122622B2 (en) * 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
US7244445B2 (en) 2002-07-29 2007-07-17 Poly Med, Inc Conformable, absorbable, solid composite preforms and their use for bone tissue engineering
US20040147532A1 (en) * 2002-10-31 2004-07-29 Pfizer Inc Liquid conjugates of solid pharmaceuticals
JP4903036B2 (ja) 2003-01-06 2012-03-21 アンジオケム・インコーポレーテッド 血液脳関門を通過する担体としてのアプロチニンおよび類似体
ES2393335T3 (es) 2003-12-16 2012-12-20 Ipsen Pharma Análogos de GLP-1
ES2877349T3 (es) 2005-07-08 2021-11-16 Ipsen Pharma Ligandos de los receptores de la melanocortina
EP2433653B1 (en) 2005-07-15 2019-06-05 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
JP2010538069A (ja) 2007-09-07 2010-12-09 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ エキセンディン−４およびエキセンディン−３の類似体
PL2214693T3 (pl) 2007-11-05 2016-03-31 Ipsen Pharma Sas Zastosowanie melanokortyn do leczenia insulinowrażliwości
EP2260060A4 (en) * 2008-04-01 2013-01-16 Univ Cornell ORGANIC SOLUBLE CHITOSA SALT AND CHITOSAN DERIVED BIOMATERIALS MANUFACTURED THEREFROM
RU2509809C2 (ru) 2008-07-04 2014-03-20 Транслэшионал Кэнсэр Драгз Фарма, С.Л. Способы лечения и диагностики рака
JP2011530506A (ja) 2008-08-07 2011-12-22 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ グルコース依存性インスリン分泌刺激ポリペプチドの切り詰められたアナログ
WO2010016944A2 (en) 2008-08-07 2010-02-11 Ipsen Pharma S.A.S. Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal
CN104829706A (zh) 2008-08-07 2015-08-12 益普生制药股份有限公司 糖依赖性胰岛素释放肽的类似物
JP5705118B2 (ja) 2008-10-15 2015-04-22 アンジオケム インコーポレーテッド 薬物送達のためのエトポシドおよびドキソルビシン複合体
WO2010043047A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
MX2011005963A (es) 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
MX2011006685A (es) 2008-12-17 2011-09-27 Angiochem Inc Inhibidores de metaloproteinas de matriz de membrana tipo-1 y sus usos.
MX2011008562A (es) 2009-02-12 2011-09-09 Proyecto Biomedicina Cima Sl Uso de la cardiotrofina-1 para el tratamiento de enfermedades metabolicas.
US9161988B2 (en) 2009-07-02 2015-10-20 Angiochem Inc. Multimeric peptide conjugates and uses thereof
JP5571186B2 (ja) 2009-07-22 2014-08-13 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ５９位にアミノ酸置換を有するインスリン様増殖因子−１（ｉｇｆ−１）の類似体
MX341642B (es) * 2011-06-14 2016-08-29 Ipsen Pharma Sas Composicion de liberacion sostenida que contiene peptidos como ingredientes activos.
US9962401B2 (en) * 2011-09-27 2018-05-08 Purdue Research Foundation Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
DK3307326T3 (da) 2015-06-15 2020-10-19 Angiochem Inc Fremgangsmåder til behandling af leptomeningeal karcinomatose

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS63258579A (ja) * 1987-04-15 1988-10-26 Fuji Boseki Kk 生理活性物質固定化用担体の製造法
US5271945A (en) * 1988-07-05 1993-12-21 Takeda Chemical Industries, Ltd. Sustained release microcapsule for water soluble drug
ATE152455T1 (de) * 1990-08-17 1997-05-15 Drug Delivery System Inst Ltd N-acetylcarboxymethylchitosanderivat und verfahren zur herstellung
US5298488A (en) * 1990-10-26 1994-03-29 Fuji Photo Film Co., Ltd. CM-chitin derivatives and use thereof
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
HUP9901627A3 (en) 1999-11-29
CN1192152A (zh) 1998-09-02
CA2222995C (en) 2005-05-10
HUP9901627A1 (hu) 1999-09-28
ES2201188T3 (es) 2004-03-16
KR19990022399A (ko) 1999-03-25
CA2222995A1 (en) 1996-12-12
WO1996039160A1 (en) 1996-12-12
PT830137E (pt) 2003-10-31
NZ308909A (en) 1999-06-29
EP0830137A1 (en) 1998-03-25
SK168397A3 (en) 1998-04-08
EP0830137A4 (en) 2002-06-26
AU5878996A (en) 1996-12-24
CZ391697A3 (cs) 1998-05-13
BR9609031A (pt) 1999-12-14
DE69629114T2 (de) 2004-04-22
RU2172323C2 (ru) 2001-08-20
AU717188B2 (en) 2000-03-23
US5665702A (en) 1997-09-09
DE69629114D1 (de) 2003-08-21
EP0830137B1 (en) 2003-07-16
ATE245031T1 (de) 2003-08-15
PL323735A1 (en) 1998-04-14
JPH11508289A (ja) 1999-07-21
DK0830137T3 (da) 2003-11-03
US5821221A (en) 1998-10-13

Similar Documents

Publication Publication Date Title
SI9620090A (sl) Ionski molekulski konjugati N-aciliranih derivatov poli (2-amino-2-deoksi-D-glukoze) in polipeptidov
Kong et al. Long acting hyaluronate–exendin 4 conjugate for the treatment of type 2 diabetes
CN101365490B (zh) 用于递送治疗剂的疏水核载体组合物及其制备方法和应用
EP2360188B1 (en) Hyaluronic acid derivative and pharmaceutical composition thereof
EP1790665B1 (en) Process for producing water-soluble modified hyaluronic acid
CN104603156B (zh) 引入有氨基酸和甾基的透明质酸衍生物
DE69432459T2 (de) Ionische molekularkonjugate von bioabbaubaren polyestern und bioaktiven polypeptiden
US9562111B2 (en) Soluble hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
US8568760B2 (en) Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof
CN114945600A (zh) 透明质酸衍生物、药物组合物和透明质酸衍生物-药物结合体
US6479457B2 (en) Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
AU738378B2 (en) Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
MXPA97009674A (es) Conjugados moleculares ionicos de derivados n-acilados de poli(2-amino-2-desoxi-d-glucosa) y polipeptidos